NYSEAMERICAN:VTAK Catheter Precision (VTAK) Stock Price, News & Analysis → Elon Musk’s Next Move Will Disrupt AI Forever (From InvestorPlace) (Ad) Free VTAK Stock Alerts $0.63 +0.03 (+4.58%) (As of 11:06 AM ET) Add Compare Share Share Today's Range$0.61▼$0.6550-Day Range N/A52-Week Range$0.34▼$1.32Volume24,207 shsAverage Volume48,853 shsMarket Capitalization$4.75 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartEarningsInsider TradesShort InterestStock AnalysisChartEarningsInsider TradesShort Interest Get Catheter Precision alerts: Email Address Catheter Precision MarketRank™ Stock AnalysisAnalyst RatingN/AUpside/DownsideN/AShort InterestHealthy0.39% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment-0.75Based on 4 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($0.87) to ($0.38) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.0.27 out of 5 stars N/A Analyst's Opinion Consensus RatingThere is not enough analysis data for Catheter Precision.Read more about Catheter Precision's stock forecast and price target. Previous Next 3.0 Short Interest Percentage of Shares Shorted0.39% of the float of Catheter Precision has been sold short.Short Interest Ratio / Days to CoverCatheter Precision has a short interest ratio ("days to cover") of 0.7, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Catheter Precision has recently increased by 28.64%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldCatheter Precision does not currently pay a dividend.Dividend GrowthCatheter Precision does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for VTAK. Previous Next 0.7 News and Social Media Coverage News SentimentCatheter Precision has a news sentiment score of -0.75. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.58 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 4 news articles for Catheter Precision this week, compared to 0 articles on an average week. Previous Next 0.8 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Catheter Precision insiders have not sold or bought any company stock.Percentage Held by Insiders18.62% of the stock of Catheter Precision is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 20.34% of the stock of Catheter Precision is held by institutions.Read more about Catheter Precision's insider trading history. Previous Next 1.3 Earnings and Valuation Earnings GrowthEarnings for Catheter Precision are expected to grow in the coming year, from ($0.87) to ($0.38) per share.Price to Book Value per Share RatioCatheter Precision has a P/B Ratio of 0.21. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Catheter Precision's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad InvestorPlaceElon Musk’s Next Move Will Disrupt AI ForeverA revolutionary venture that is set to get rolled out by May 16. One well-connected Silicon Valley VC has uncovered a way for anybody to claim a stake in "Elon Musk's AI 2.0" with as little as $100.Get all the information here. About Catheter PrecisionCatheter Precision, Inc. develops and delivers electrophysiology products to provide patients, hospitals, and physicians with technologies and solutions to improve the lives of patients with cardiac arrhythmias in the United States. The company's lead product is View into Ventricular Onset System, a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. It also provides LockeT, a suture retention device; and Amigo Remote Catheter System, a robotic arm that serves as a catheter control device. The company was formerly known as Ra Medical Systems, Inc and changed its name to Catheter Precision, Inc. in August 2023. Catheter Precision, Inc. is based in Fort Mill, South Carolina.Read More VTAK Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart VTAK Stock News HeadlinesMay 7, 2024 | investorplace.comVTAK Stock Earnings: Catheter Precision, Inc. Common Stock Beats EPS, Misses Revenue for Q1 2024See More Headlines Receive VTAK Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Catheter Precision and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/06/2024Today5/13/2024Next Earnings (Estimated)5/31/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSEAMERICAN SectorMedical Industry Surgical & medical instruments Sub-IndustryN/A Current SymbolNYSEAMERICAN:VTAK CUSIPN/A CIKN/A Webwww.catheterprecision.com Phone973-691-2000FaxN/AEmployees14Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-70,570,000.00 Net Margins-1,559.68% Pretax Margin-1,559.68% Return on Equity-9.37% Return on Assets-6.29% Debt Debt-to-Equity RatioN/A Current Ratio0.83 Quick Ratio1.67 Sales & Book Value Annual Sales$440,000.00 Price / Sales10.32 Cash FlowN/A Price / Cash FlowN/A Book Value$2.45 per share Price / Book0.24Miscellaneous Outstanding Shares7,570,000Free Float6,163,000Market Cap$4.54 million OptionableN/A Beta-0.19 Beginners Guide To Retirement StocksClick the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report Key ExecutivesMr. David A. Jenkins (Age 66)CEO & Executive Chairman Comp: $306.6kMs. Margrit Thomassen CPAInterim Chief Financial Officer & SecretaryMs. Missiaen HuckChief Operating OfficerKey CompetitorsSharps TechnologyNASDAQ:STSSEKIMASOTCMKTS:ASNBVenus ConceptNASDAQ:VEROUnited American HealthcareOTCMKTS:UAHCArch TherapeuticsOTCMKTS:ARTHView All CompetitorsInsidersDavid A JenkinsBought 9,528 shares on 1/22/2024Total: $4,097.04 ($0.43/share)David A JenkinsBought 8,470 shares on 1/18/2024Total: $3,472.70 ($0.41/share)David A JenkinsBought 16,263 shares on 1/16/2024Total: $6,342.57 ($0.39/share)View All Insider Transactions VTAK Stock Analysis - Frequently Asked Questions Are investors shorting Catheter Precision? Catheter Precision saw a increase in short interest in April. As of April 30th, there was short interest totaling 25,600 shares, an increase of 28.6% from the April 15th total of 19,900 shares. Based on an average trading volume of 35,600 shares, the days-to-cover ratio is currently 0.7 days. Currently, 0.4% of the company's stock are sold short. View Catheter Precision's Short Interest. When is Catheter Precision's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Friday, May 31st 2024. View our VTAK earnings forecast. How were Catheter Precision's earnings last quarter? Catheter Precision, Inc. (NYSEAMERICAN:VTAK) posted its earnings results on Monday, May, 6th. The company reported ($0.36) earnings per share (EPS) for the quarter. The firm earned $0.08 million during the quarter. Catheter Precision had a negative trailing twelve-month return on equity of 9.37% and a negative net margin of 1,559.68%. How do I buy shares of Catheter Precision? Shares of VTAK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSEAMERICAN:VTAK) was last updated on 5/13/2024 by MarketBeat.com Staff From Our PartnersDoes this make you sick?Allegiance GoldExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersThis 1 Biotech Stock has been shocking the marketsHuge AlertsThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorNext President (Not Trump. Not Biden.)The Freeport SocietyThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldHe Is Giving Away BitcoinCrypto Swap ProfitsHow Biden has already won 2024Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Catheter Precision, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
